Laetrile, Hypothermia, Breast, Brain, Prostate, Cancer
In this video, Gilberto Alvarez spends about 26 minutes speaking on "Laetrile, Hypothermia, Breast, Brain, Prostate, Cancer" at the 45th Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Dr. Gilberto Alvarez
Dr. Gilberto Alvarez is a medical doctor who graduated from the National Autonomous University in Mexico City and practices medicine in both Mexico and the United States. He has over 37 years of experience and a longtime practice in integrative and natural medicine for cancer patients. Between the years 1977 and 1981, he worked with Dr. Ernesto Contreras, a well-recognized doctor, founder of Oasis of Hope clinic in Tijuana, and the first doctor to have brought the German methods of therapy to Mexico.
Between 1982 and 1992 he was the medical director at Dr. Harold W. Manner’s clinic, pioneering in nutritional therapy based on laetrile and vitamins. Later on, Dr. Alvarez became the medical director at Stella Maris from 1993 until today. He participated on Proteolytic Enzyme Therapy in Munich, Germany with Dr. Karl Ransberger. He then became a member of the International Clinical Hyperthermia Society (ICHS) in Florence, Italy in 2005. His experience in cancer and other disorders is extensive, and he implements his expertise in different programs given at his clinic.
On a personal level, Dr. Alvarez is a warm person who sees the patient as a whole and shows genuine caring and empathy. He answers patients’ calls personally before and after treatment.
Transcription
Thank you very much. And good evening. And first of all, I'd like to introduce my son, who's also a physician. You better believe it is Junior and his the first time he's coming with me.
So he's is on all be able to share our experience that we have accumulated in our during my 37 year of practice. That's still Mars clinic. And let me anticipate that the Irish are treatment practice has been changing for the last few years.
And this is related to the fact that we are dealing with more aggressive cancer behaviors and more resistant tumors and. Seeing people developing cancer at a more earlier age. So. And that accounts you to about 20, 30 percent of our patients where we have combined different modalities. And I'm talking about we are solution or moving therapies with a biologic therapies and also some low dose effective conventional therapies. So. So let me start with my first slide. And this is the typical cases that we happen to see on on your on your right side. You find a patient with breast cancer. This is an inflammatory breast cancer, which happens to be the most aggressive dove of breast cancer. So this is the way we receive our patients. And after going through the process of art therapy, we you can see the next slide. And the is that we have seen and in these particular patients. This is a very sad case as well. This is another patient that we receive, a very young person coming from Portugal. And this is the period the IRA is showing. She first came into the clinic. But on the next one, you can see the the the follow up picture. And how this patient has been responding to the therapy. And prostate cancer is another important, the cancer that we happen to see at the clinic. And we can see this patient with it, you can see the ease into his eyes. You can see that the eye, the left eye has been pushed the upward and downward. And this is related to the cancer metastasized into the bones where this patient was losing his eyesight. But nevertheless, you can see on the next one how well he. This patient had been where he recover his eyesight, then doing very important progress. A lot of this has to do with thermal or silver system, where the name what they shown, as well as the sialic acid, which is the protein codes that surround the cancer cells and the B 52 factor. All of these in play A play a very important role in in making these cells to be